Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter CDK4 Antikörper (N-Term)

Dieser Kaninchen Monoklonal Antikörper detektiert spezifisch CDK4 in WB und IHC. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN7860785
639,45 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach: Deutschland
Lieferung in 6 bis 10 Werktagen

Kurzübersicht für Rekombinanter CDK4 Antikörper (N-Term) (ABIN7860785)

Target

Alle CDK4 Antikörper anzeigen
CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 165
  • 83
  • 67
  • 19
  • 8
  • 7
  • 5
  • 4
  • 3
  • 1
  • 1
  • 1
Human

Wirt

  • 134
  • 49
  • 2
Kaninchen

Klonalität

  • 94
  • 90
Monoklonal

Konjugat

  • 115
  • 11
  • 9
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CDK4 Antikörper ist unkonjugiert

Applikation

  • 145
  • 62
  • 48
  • 47
  • 44
  • 39
  • 24
  • 21
  • 14
  • 13
  • 7
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)

Klon

CDK4-8351R
  • Bindungsspezifität

    • 19
    • 16
    • 16
    • 14
    • 9
    • 8
    • 8
    • 7
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    N-Term

    Verwendungszweck

    Recombinant CDK4 Antibody

    Spezifität

    Cyclin-dependent kinase-4 (CDK4) is a protein-serine kinase involved in the cell cycle. It is essential for the G1- to S-phase transition during the cell cycle and its expression is primarily controlled at the transcriptional level (PMID:17253961). CCND1- CDK4 axis is not only critical in glial tumor cells but also in stromal-derived cells in the surrounding tumor microenvironment that are vital to sustain tumor outgrowth (PMID:21844184). CDK4 is highly expressed in highly differentiated and dedifferentiated liposarcomas, but rarely expressed in other benign liposarcomas and other sarcomas. CDK4 and MDM2 combined to differentiate between highly differentiated liposarcoma (+), dedifferentiated liposarcoma (+) and myxoid liposarcoma, pleomorphic liposarcoma, spindle lipoma, pleomorphic lipoma and other high-grade sarcomas.

    Aufreinigung

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogen

    Recombinant fragment corresponding to N-terminal of human CDK4 protein

    Isotyp

    IgG, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Target

    CDK4 (Cyclin-Dependent Kinase 4 (CDK4))

    Andere Bezeichnung

    CDK4

    Hintergrund

    CDK4 protein, CDK4_HUMAN, Cell division protein kinase 4, CMM3, Crk3, Cyclin dependent kinase 4, Melanoma cutaneous malignant 3, MGC14458, p34 cdk4, PSK-J3

    MCF7, HEK293T, cervical carcinoma and liposarcomas.|Human urothelial carcinoma, HeLa

    Molekulargewicht

    34kDa

    Gen-ID

    1019, 95577

    Pathways

    Zellzyklus, Mitotic G1-G1/S Phases, Regulation of Cell Size
Sie sind hier:
Chat with us!